Cargando…

Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy

BACKGROUND: Posttreatment diffusion–weighted magnetic resonance imaging (DW‐MRI) and 18F‐fluorodeoxygluocose ((18)F‐FDG) positron emission tomography (PET) with computed tomography (PET/CT) have potential prognostic value following chemo‐radiotherapy (CRT) for head and neck squamous cell carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Connor, Steve, Sit, Cherry, Anjari, Mustafa, Szyszko, Teresa, Dunn, Joel, Pai, Irumee, Cook, Gary, Goh, Vicky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388179/
https://www.ncbi.nlm.nih.gov/pubmed/33960739
http://dx.doi.org/10.1002/cnr2.1360
_version_ 1783742591576047616
author Connor, Steve
Sit, Cherry
Anjari, Mustafa
Szyszko, Teresa
Dunn, Joel
Pai, Irumee
Cook, Gary
Goh, Vicky
author_facet Connor, Steve
Sit, Cherry
Anjari, Mustafa
Szyszko, Teresa
Dunn, Joel
Pai, Irumee
Cook, Gary
Goh, Vicky
author_sort Connor, Steve
collection PubMed
description BACKGROUND: Posttreatment diffusion–weighted magnetic resonance imaging (DW‐MRI) and 18F‐fluorodeoxygluocose ((18)F‐FDG) positron emission tomography (PET) with computed tomography (PET/CT) have potential prognostic value following chemo‐radiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC). Correlations between these PET/CT (standardized uptake value or SUV) and DW‐MRI (apparent diffusion coefficient or ADC) parameters have only been previously explored in the pretreatment setting. AIM: To evaluate stage III and IV HNSCC at 12‐weeks post‐CRT for the correlation between SUV(max) and ADC values and their interval changes from pretreatment imaging. METHODS: Fifty‐six patients (45 male, 11 female, mean age 59.9 + − 7.38) with stage 3 and 4 HNSCC patients underwent 12‐week posttreatment DW‐MRI and (18)F‐FDG PET/CT studies in this prospective study. There were 41/56 patients in the cohort with human papilloma virus‐related oropharyngeal cancer (HPV OPC). DW‐MRI (ADC(max) and ADC(min)) and (18)F‐FDG PET/CT (SUV(max) and SUV(max) ratio to liver) parameters were measured at the site of primary tumors (n = 48) and the largest lymph nodes (n = 52). Kendall's tau evaluated the correlation between DW‐MRI and (18)F‐FDG PET/CT parameters. Mann‐Whitney test compared the post‐CRT PET/CT and DW‐MRI parameters between those participants with and without 2‐year disease‐free survival (DFS). RESULTS: There was no correlation between DW‐MRI and (18)F‐FDG PET/CT parameters on 12‐week posttreatment imaging (P = .455‐.794; tau = −0.075‐0.25) or their interval changes from pretreatment to 12‐week posttreatment imaging (P = .1‐.946; tau = −0.194‐0.044). The primary tumor ADC(mean) (P = .03) and the interval change in nodal ADC(min) (P = .05) predicted 2‐year DFS but none of the (18)F‐FDG PET/CT parameters were associated with 2‐year DFS. CONCLUSIONS: There is no correlation between the quantitative DWI‐MRI and (18)F‐FDG PET/CT parameters derived from 12‐week post‐CRT studies. These parameters may be independent biomarkers however in this HPV OPC dominant cohort, only selected ADC parameters demonstrated prognostic significance. Study was prospectively registered at http://www.controlled-trials.com/ISRCTN58327080
format Online
Article
Text
id pubmed-8388179
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83881792021-08-31 Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy Connor, Steve Sit, Cherry Anjari, Mustafa Szyszko, Teresa Dunn, Joel Pai, Irumee Cook, Gary Goh, Vicky Cancer Rep (Hoboken) Original Articles BACKGROUND: Posttreatment diffusion–weighted magnetic resonance imaging (DW‐MRI) and 18F‐fluorodeoxygluocose ((18)F‐FDG) positron emission tomography (PET) with computed tomography (PET/CT) have potential prognostic value following chemo‐radiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC). Correlations between these PET/CT (standardized uptake value or SUV) and DW‐MRI (apparent diffusion coefficient or ADC) parameters have only been previously explored in the pretreatment setting. AIM: To evaluate stage III and IV HNSCC at 12‐weeks post‐CRT for the correlation between SUV(max) and ADC values and their interval changes from pretreatment imaging. METHODS: Fifty‐six patients (45 male, 11 female, mean age 59.9 + − 7.38) with stage 3 and 4 HNSCC patients underwent 12‐week posttreatment DW‐MRI and (18)F‐FDG PET/CT studies in this prospective study. There were 41/56 patients in the cohort with human papilloma virus‐related oropharyngeal cancer (HPV OPC). DW‐MRI (ADC(max) and ADC(min)) and (18)F‐FDG PET/CT (SUV(max) and SUV(max) ratio to liver) parameters were measured at the site of primary tumors (n = 48) and the largest lymph nodes (n = 52). Kendall's tau evaluated the correlation between DW‐MRI and (18)F‐FDG PET/CT parameters. Mann‐Whitney test compared the post‐CRT PET/CT and DW‐MRI parameters between those participants with and without 2‐year disease‐free survival (DFS). RESULTS: There was no correlation between DW‐MRI and (18)F‐FDG PET/CT parameters on 12‐week posttreatment imaging (P = .455‐.794; tau = −0.075‐0.25) or their interval changes from pretreatment to 12‐week posttreatment imaging (P = .1‐.946; tau = −0.194‐0.044). The primary tumor ADC(mean) (P = .03) and the interval change in nodal ADC(min) (P = .05) predicted 2‐year DFS but none of the (18)F‐FDG PET/CT parameters were associated with 2‐year DFS. CONCLUSIONS: There is no correlation between the quantitative DWI‐MRI and (18)F‐FDG PET/CT parameters derived from 12‐week post‐CRT studies. These parameters may be independent biomarkers however in this HPV OPC dominant cohort, only selected ADC parameters demonstrated prognostic significance. Study was prospectively registered at http://www.controlled-trials.com/ISRCTN58327080 John Wiley and Sons Inc. 2021-05-07 /pmc/articles/PMC8388179/ /pubmed/33960739 http://dx.doi.org/10.1002/cnr2.1360 Text en © 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Connor, Steve
Sit, Cherry
Anjari, Mustafa
Szyszko, Teresa
Dunn, Joel
Pai, Irumee
Cook, Gary
Goh, Vicky
Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
title Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
title_full Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
title_fullStr Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
title_full_unstemmed Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
title_short Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
title_sort correlations between dw‐mri and (18)f‐fdg pet/ct parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388179/
https://www.ncbi.nlm.nih.gov/pubmed/33960739
http://dx.doi.org/10.1002/cnr2.1360
work_keys_str_mv AT connorsteve correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy
AT sitcherry correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy
AT anjarimustafa correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy
AT szyszkoteresa correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy
AT dunnjoel correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy
AT paiirumee correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy
AT cookgary correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy
AT gohvicky correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy